Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of a 2-year continuing professional development programme to change Japanese physicians' attitudes to learning primary care: a qualitative study.

BMJ open·2022
Same author

Association Between Kidney Function Decline and Baseline TNFR Levels or Change Ratio in TNFR by Febuxostat Chiefly in Non-diabetic CKD Patients With Asymptomatic Hyperuricemia.

Frontiers in medicine·2021
Same author

Effect of uric acid levels on mortality in Japanese peritoneal dialysis patients.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2020
Same author

How a problem-based learning approach could help Japanese primary care physicians: a qualitative study.

International journal of medical education·2019
Same author

Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study.

PloS one·2019
Same author

Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2018

Related Experiment Video

Updated: Jul 6, 2026

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

[Uricosuric agent].

Iwao Ohno1

  • 1Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 16, 2008
PubMed
Summary
This summary is machine-generated.

Urate-lowering treatments, including uricosuric agents and allopurinol, manage hyperuricemia in gout patients. Proper urinary tract management is crucial to prevent complications like kidney stones when using uricosuric medications.

Related Experiment Videos

Last Updated: Jul 6, 2026

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

Area of Science:

  • Nephrology
  • Rheumatology
  • Pharmacology

Context:

  • Gout management requires urate-lowering treatment for patients with recurrent attacks, tophi, or joint damage.
  • Hyperuricemia can lead to complications such as nephrolithiasis.
  • Pharmacological options include xanthine oxidase inhibitors and uricosuric agents.

Purpose:

  • To outline the indications for urate-lowering therapy in gout.
  • To describe the mechanism of action of uricosuric agents.
  • To emphasize the importance of urinary tract management when using uricosuric agents.

Summary:

  • Urate-lowering treatment is indicated for symptomatic gout, including recurrent attacks, tophi, arthropathy, and nephrolithiasis.
  • Uricosuric agents (e.g., benzbromarone, probenecid) and allopurinol are key treatments for hyperuricemia.
  • Uricosuric agents block the URAT1 transporter in renal proximal tubules, increasing urate excretion.

Impact:

  • Highlights the necessity of adequate urine volume and pH correction to mitigate nephrotoxicity and urolithiasis risks.
  • Provides essential information for clinicians managing gout patients on uricosuric therapy.
  • Aids in optimizing treatment strategies to prevent adverse renal events associated with gout medications.